Jeffrey Lewis. (Courtesy photo)
Norton Rose Fulbright on Tuesday announced that it has hired Jeffrey Lewis, a patent litigator and past president of the American Intellectual Property Law Association, as a partner in the global law firm’s New York office.
Lewis, whose practice includes a focus on pharmaceutical patent litigation under the Hatch-Waxman Act, comes to Norton Rose after a little more than two years at Fried, Frank, Harris, Shriver & Jacobson, which he joined in March 2015. Prior to that, he had spent more than two decades at Patterson Belknap Webb & Tyler, where he headed the firm’s patent group before departing.
In a statement Tuesday, Norton Rose touted the addition of Lewis as a boon for both the firm’s expanding New York outpost and its IP practice.
“Having grown into one of the 25 largest law firm offices in New York, we are becoming an even more attractive destination for world-class lawyers seeking a global platform. Jeff will bolster our IP practice and provide patent litigation capabilities that our clients desire,” Daryl Lansdale, U.S. managing partner of Norton Rose, said.
Gina Shishima, head of U.S. intellectual property at the firm, added that Lewis’ expertise “greatly complements our existing team.”
Lewis, who holds an undergraduate degree in chemical engineering, has been active outside of his law practice in legal professional groups, including AIPLA, the New York Intellectual Property Law Association and the American Bar Association’s IP section. He is currently an AIPLA and ABA fellow, according to Norton Rose, and he served as AIPLA’s president for the 2012-2013 term.
He has also been counsel of record for AIPLA in connection with amicus briefs filed in key U.S. Supreme Court cases touching on IP law, including 2014′s Limelight Networks v. Akamai Technologies—a case that raised questions about divided infringement when multiple parties complete the steps of a method patent. In addition to patent litigation, Lewis’ practice includes trademark and other kinds of IP matters, according to Norton Rose.
Lewis said in a statement that he believes his move to Norton Rose will afford him a platform to address IP issues for clients around the globe.
“Norton Rose Fulbright offers a tremendous opportunity to work with some of the very best lawyers around the world,” Lewis said. “The firm’s reach allows me to serve clients with a wide range of complex IP issues globally.”